| Glioma | GBMLGG | 1-MT | CD4+ T cells | CD4-CD28+ T cell | mouse model | 26636389 | Details |  |  |  |  |
| Glioma | GBMLGG | 1-MT | CD4+ T cells | CD4-CD28- T cell | mouse model | 26636389 | Details | | | | |
| Glioma | GBMLGG | 1-MT | CD4+ T cells | CD4+ T helper cell | mouse model | 26636389 | Details | | | | |
| Glioma | GBMLGG | 1-MT | CD4+ T cells | CD4+CD25+ regulatory T cell | mouse model | 26636389 | Details | | | | |
| Glioma | GBMLGG | 1-MT | CD4+ T cells | CD4+ cytotoxic T cell | mouse model | 26636389 | Details | | | | |
| Glioma | GBMLGG | 1-MT | CD4+ T cells | CD4+ T cell | mouse model | 26636389 | Details | | | | |
| Glioma | GBMLGG | 1-MT | CD8+ T cells | Naive CD8+ T cell | mouse model | 26636389 | Details | | | | |
| Glioma | GBMLGG | 1-MT | CD8+ T cells | Effector CD8+ memory T (Tem) cell | mouse model | 26636389 | Details | | | | |
| Glioma | GBMLGG | 1-MT | CD8+ T cells | Exhausted CD8+ T cell | mouse model | 26636389 | Details | | | | |
| Glioma | GBMLGG | 1-MT | CD8+ T cells | CD8+ T cell | mouse model | 26636389 | Details | | | | |
| Glioma | GBMLGG | 1-MT | CD8+ T cells | CD8+ cytotoxic T cell | mouse model | 26636389 | Details | | | | |
| Glioma | GBMLGG | agonist anti-OX40 monoclonal antibody | IFN-γ | IFNG | mouse model | 29016879 | Details | | | | |
| Glioma | GBMLGG | agonist anti-OX40 monoclonal antibody | TNF-α | TNF | mouse model | 29016879 | Details | | | | |
| Glioma | GBMLGG | agonist anti-OX40 monoclonal antibody | IL-2 | IL2 | mouse model | 29016879 | Details | | | | |
| Glioma | GBMLGG | agonist anti-OX40 monoclonal antibody | granzyme B | GZMB | mouse model | 29016879 | Details | | | | |
| Glioma | GBMLGG | agonist anti-OX40 monoclonal antibody | PD-1 | PDCD1 | mouse model | 29016879 | Details | | | | |
| Glioma | GBMLGG | agonist anti-OX40 monoclonal antibody | LAG-3 | LAG3 | mouse model | 29016879 | Details | | | | |
| Glioma | GBMLGG | agonist anti-OX40 monoclonal antibody | TIM-5 | TIMM50 | mouse model | 29016879 | Details | | | | |
| Glioma | GBMLGG | ipilimumab | CTLA-4 | CTLA4 | mouse model | 28129117 | Details | | | | |
| Glioma | GBMLGG | nivolumab | PD-1 | PDCD1 | mouse model | 28129117 | Details | | | | |
| Glioma | GBMLGG | pembrolizumab | PD-1 | PDCD1 | mouse model | 28129117 | Details | | | | |
| Glioma | GBMLGG | TK/Flt3L | Flt3L | FLT3LG | clinical trail | 28129117 | Details | | | | |
| Glioma | GBMLGG | Erk1-/- DC | CD8+ T cells | Naive CD8+ T cell | mouse model | 27256374 | Details | | | | |
| Glioma | GBMLGG | Erk1-/- DC | CD8+ T cells | Effector CD8+ memory T (Tem) cell | mouse model | 27256374 | Details | | | | |
| Glioma | GBMLGG | Erk1-/- DC | CD8+ T cells | Exhausted CD8+ T cell | mouse model | 27256374 | Details | | | | |
| Glioma | GBMLGG | Erk1-/- DC | CD8+ T cells | CD8+ T cell | mouse model | 27256374 | Details | | | | |
| Glioma | GBMLGG | Erk1-/- DC | CD8+ T cells | CD8+ cytotoxic T cell | mouse model | 27256374 | Details | | | | |